Physician

Rebekah Gensure, M.D., PH.D.

According to 2025 Medicare claims, Rebekah Gensure, M.D., PH.D. (NPI: 1225490444) practices ophthalmology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is SALT LAKE RETINA, LLC (NPI: 1144622234; TIN: 47-1293676) and primary practice location at 84107-2105.

Gensure's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 241 traditional Medicare patients, billed 12,354 HCPCS/CPT codes, and received $1,146,803 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 154 prescription claims across 59 beneficiaries totaling $3,850 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $565. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,668 to $1,146,803. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $245 and ending at $3,850. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$573K$1.1M2020 Medicare payment: $8,668 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $24,725 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $230,313 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,014,090 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,146,803 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20206382$8,668
2021111182$24,725
20221941,600$230,313
202323410,901$1,014,090
202424112,354$1,146,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.8K$20K2017 Drug cost: $245 (USD; Tot_Drug_Cst)2018 Drug cost: $6,549 (USD; Tot_Drug_Cst)2019 Drug cost: $3,337 (USD; Tot_Drug_Cst)2020 Drug cost: $10,864 (USD; Tot_Drug_Cst)2021 Drug cost: $19,641 (USD; Tot_Drug_Cst)2022 Drug cost: $14,348 (USD; Tot_Drug_Cst)2023 Drug cost: $4,270 (USD; Tot_Drug_Cst)2024 Drug cost: $3,850 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171320$245
201847152$6,549
20193892$3,337
2020101236$10,864
2021158417$19,641
2022106257$14,348
202347131$4,270
202459154$3,850

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg761,080$657
67028Injection of drug into eye130698$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more135158$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more99157$64
92134Imaging of retina219749$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate621,487$2,059
OfloxacinOfloxacin45834$516
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat191,236$265

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$565Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rebekah Gensure, M.D., PH.D.?

Tedicare shows public-source Medicare data for Rebekah Gensure, M.D., PH.D. (NPI 1225490444), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rebekah Gensure, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rebekah Gensure, M.D., PH.D.?

Rebekah Gensure, M.D., PH.D. is linked to SALT LAKE RETINA, LLC (billing NPI 1144622234) in the available physician profile data.

Does Rebekah Gensure, M.D., PH.D. have Open Payments data?

Rebekah Gensure, M.D., PH.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.